Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509379
Status:
COMPLETED
Last Update Posted:
2011-01-28
First Post:
2007-07-30
Brief Title:
Non-randomized Safety Study With BortezomibRituximab in RelapsedRefractory Indolent Lymphoma
Sponsor:
Organization:
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie